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http://www.biomedcentral.com/2052-9538/1/1/14RESEARCH ARTICLE Open AccessCortisol, alpha amylase, blood pressure and heart
rate responses to food intake in men aged 50–70
years: importance of adiposity
Sisitha U Jayasinghe1, Susan J Torres1, Caryl A Nowson1, Alan J Tilbrook2 and Anne I Turner1*Abstract
Background: Increased adiposity is often associated with over activation of the hypothalamo-pituitary adrenal axis
(HPA axis) and the sympatho-adrenal medullary system (SAM system) and excessive activation of these pathways in
response to physiological challenges may be linked with the development of diseases. We tested the hypothesis
that overweight/obese men aged 50–70 years will have greater HPA axis and SAM system responses to food intake
compared with age matched lean men.
Lean (Body Mass Index; BMI = 20-25 kg/m2; n = 19) and overweight/obese (BMI = 27-35 kg/m2; n = 17) men (50–70
years) made their own lunch using standardised ingredients at 1200 h. Concentrations of cortisol and alpha
amylase were measured in saliva samples collected every 15 min from 1145 h-1400 h with the exception of during
lunch (1215 h) where no sample was collected. Blood pressures and heart rate were measured at 1145 h and every
15 minutes between 1245 h and 1400 h.
Results: Overweight/obese men had significantly higher body weight, BMI, percentage body fat and waist and hip
circumferences compared to lean men (p < 0.001 for all). The meal consumed by the participants consisted of 22%
protein, 53% carbohydrates and 25% fat. Overweight/obese men responded to lunch with a significant increase in
cortisol whereas lean men did not show such an increase (time*treatment p = 0.008). There were no significant
differences between the groups in the salivary alpha amylase response to the meal (time*treatment p = 0.195) or in
SBP, DBP, MAP or HR responses (time*treatment p = 0.726, 0.898, 0.713, 0.620, respectively).
Conclusions: While men with a moderate level of overweight/obesity had a significant HPA axis response (as measured
by salivary cortisol) to a standardised lunch, lean men had no HPA axis response. Lean and overweight/obese men had
similar increases in SAM system activity (as measured by salivary alpha amylase) in response to the meal.
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Exposure to stress activates the SAM system (which re-
sults in increases in salivary alpha amylase, blood pres-
sure and heart rate) and the HPA axis (which results in
increases in salivary cortisol) [1]. Hyperactivity of these
pathways can be associated with the development of nu-
merous chronic conditions including cardiovascular dis-
ease, type 2 diabetes, anxiety and depression [2]. Obesity
is a worldwide epidemic and is associated with numer-
ous health complications and increased morbidity [3].* Correspondence: anne.turner@deakin.edu.au
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article, unless otherwise stated.Animal studies by our research group as well as others
suggest that obesity can be associated with increased
HPA axis and SAM system responses to stress [4,5]. Evi-
dence from human studies is not conclusive in this re-
gard. Some studies have suggested hyperactivity of the
stress pathways in obesity in response to various stressors
such as postural challenges, video game challenges, expos-
ure to cold, mental arithmetic challenges and pharmaco-
logical stimulation [6-8]. Others have suggested that
there is no association between increased adiposity and
stress pathway activation or that increased adiposity is
associated with lower stress pathway activation to
similar stressors [9-11].tral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/4.0), which permits unrestricted use,
, provided the original work is properly credited. The Creative Commons Public
mons.org/publicdomain/zero/1.0/) applies to the data made available in this
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vate the HPA axis [12-14]. Gibson and colleagues re-
ported that a high protein (32% of energy in protein)
mid-day meal can elicit greater (1.5 -2 fold increase)
HPA axis responses compared with a low protein (5% of
energy in protein) mid-day meal in young healthy fe-
males [12]. They also showed that a high protein meal
(39% energy in protein) can elicit a significant HPA axis
response in young men [12]. Nevertheless, Martens and
colleagues measured cortisol responses in men to three
different types of shakes (high protein shake, high carbo-
hydrate shake and high fat shake) and reported that only
the high carbohydrate shake resulted in an increase in
cortisol secretion [14]. Each of the shakes used con-
tained 2306 ± 77 kJ. Furthermore, Vicennati and col-
leagues reported that only high carbohydrate meals (89%
carbohydrate, 11% protein, 0% fat) but not high protein/
fat meals (53% lipids, 43% protein and 4% carbohydrate)
resulted in a significant HPA axis response in women
who predominantly had a visceral body fat distribution
compared with women with peripheral body fat distribu-
tion and normal weight healthy controls [13]. Therefore,
it appears that the evidence in humans in this area is in-
conclusive. None of the past studies in this area have
considered the activation of the SAM system responsive-
ness to ingestion of food. Thus, there is a paucity of evi-
dence on SAM system reactivity to consumption of
food. Furthermore, no previous studies have investigated
the effects of adiposity on HPA axis and SAM system ac-
tivity in lean and overweight/obese men in response to
food intake. Since food intake is a challenge experienced
by the human body several times per day, a greater under-
standing of the influence of adiposity on the physiological
response to food intake is of fundamental importance. If
overweight/obese men have a greater activation of the
stress pathways every time they consume food it is plaus-
ible that they may be more susceptible to the development
of stress-related diseases.
Research shows that, during challenges, activation of the
SAM system increases the secretion of alpha amylase by
the salivary glands [15-18]. Simple sampling procedures of
saliva makes salivary alpha amylase a useful non-invasive
measure of SAM system activity [19]. Further advantages
of salivary alpha amylase include its concentration being
independent of the salivary flow rate [18].
Activation of the HPA axis by stress results in the sequen-
tial secretion of corticotrophin releasing hormone (CRH)
and arginine vasopressin (AVP) from the hypothalamus, ad-
renocorticotrophic hormone (ACTH) from the anterior pi-
tuitary gland and glucocorticoids such as cortisol from the
adrenal cortex [20,21]. Changes in the above parameters are
used as markers of the activity of these stress pathways.
The aim of this investigation was to identify differ-
ences between lean and overweight/obese men in HPAaxis responses (measured via salivary cortisol) and SAM
system responses (measured via salivary alpha amylase) to
the consumption of a standardised lunch. It was hypothe-
sised that overweight/obese men will have greater salivary
cortisol and salivary alpha amylase responses to the stan-
dardised lunch compared with lean men.
Methods
Participants
Men aged 50–70 years were recruited using newspaper
and online advertisements, fliers in community centres
and Medical Clinics, mail outs to participants of previ-
ous studies and by fliers dropped in mail boxes. Exclusion
criteria were prior diagnosis with Cushing’s syndrome, any
stress or anxiety disorder, depression, diseases of the ad-
renal gland, type 2 diabetes, heart disease (including use
of a pacemaker), high cholesterol, stroke, cancer or use of
blood pressure or diabetes medication. Men were also ex-
cluded if their BMI fell outside of the required ranges
(20–25 kg/m2 for lean and 27–35 kg/m2 for overweight/
obese), if their resting blood pressure exceeded 160 mmHg
for systolic blood pressure or 90 mmHg for diastolic blood
pressure.
Written informed consent was provided by all men prior
to participation in the study. All procedures were approved
by the Human Research Ethics Committee of Deakin
University (Project code: EC00213) and conformed to
the guidelines of the National Health and Medical Research
Council’s National Statement on Ethical Conduct in
Human Research (2007).
Experimental procedure
Participants were asked to abstain from smoking, ingest-
ing any caffeine containing beverages (e.g. tea, coffee,
cola), liquorice, alcohol or drugs (except for any regular
medications) and from strenuous physical activity during
the 12 hours prior to participation in the study. They
were asked to arrive at the laboratory at 1100 h and they
were given a standardised lunch at 1200 h. The first sal-
iva sample was collected at 1145 h, the second one at
1200 h (immediately before lunch), third at 1230 h and
subsequent samples were collected every 15 minutes
until 1400 h. Systolic blood pressure (SBP), diastolic
blood pressure (DBP), mean arterial pressure (MAP) and
heart rate (HR) were measured using a clinical blood
pressure monitor (Criticare systems Inc, Wisconsin, USA)
at 1145 h, 1245 h and every 15 minutes from there on-
wards until 1400 h. Participants were allowed a break to
use the bathroom immediately after the 1330 h saliva and
blood pressure/heart rate sampling.
Anthropometric measures
Participant’s height (Measurement Concepts, North Bend,
Australia), body weight (TANITA, Wedderburn, Melbourne,
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impedance (TANITA, Wedderburn, Melbourne, Australia)
were measured at the start of the experimental day. Body
mass index (BMI) was calculated using the equation
BMI = body mass (kg)/height (m)2. Waist circumfer-
ence was measured at the midpoint between the last
rib and the anterior superior iliac spine using a tape
measure and hip circumference was measured at the
widest point of the gluteal area [22]. Waist to hip ratio
was calculated by dividing waist circumference by hip
circumference.
Test meal
The test meal consisted of lunch made by the partici-
pants from a choice of standardised ingredients includ-
ing bread, margarine, processed meat (ham or chicken),
tomato, cucumber, cheese, nuts, fruit bars and a fruit
drink (juice box). Water was available ad libitum. Re-
cords were collected of foods and quantities consumed in
household measures. Foods consumed were entered into
and analysed using FoodWorks software (Xyris, Queensland,
Australia).
Saliva sampling
Salivette sampling tubes (Sarstedt, Ingle Farm, Australia)
were used for sample collection. These tubes consist of a
centrifugation tube and a cotton swab. Participants were
instructed to hold the cotton swab in their mouth for
2 minutes. They were asked to put the cotton swab
under their tongue for the first 30–45 seconds and to
move it around the oral cavity for the remainder of the
duration without chewing it or holding it between their
teeth. Temporary storage of samples on ice occurred im-
mediately after collection and samples were centrifuged
at 2000 rpm for 5 minutes at 4°C after the testing period.
Resultant saliva was stored at −80°C until assayed. Since
the measurement of saliva cortisol has been shown to be
unaffected by blood contamination due to micro-injury
of the oral cavity [23], we did not perform haemoglobin
assays in saliva to check for blood contamination. This
approach is in accordance with previous research [12,24]
that has considered salivary cortisol concentrations in
response to food intake.
Saliva cortisol assays
Saliva concentrations of cortisol were measured using an
enzyme immunoassay (Diagnostic Systems Laboratories,
TX, USA). All samples from a single participant were
assayed within the same assay. Thirty-one assays were
conducted with a mean sensitivity of 0.035 μg/dL. The
intra-assay coefficient of variation was 6.9% at 0.25 μg/
dL and 8.2% at 2.0 μg/dL. The inter-assay coefficient of
variation was 9.4% at 0.28 μg/dL and 7.7% at 1.8 μg/dL.Salivary alpha amylase assays
Saliva concentrations of alpha amylase were measured
using a kinetic assay kit (Salimetrics, PA, USA). All sam-
ples from a single participant were assayed within the
same assay. Thirty-six assays were conducted with a
mean sensitivity of 0.4 U/ml. The intra-assay coefficient
of variation was 7.4% at 156.3 ± 4.1 U/ml. The inter-
assay coefficient of variation was 7.4% at 20.7 U/ml and
7.0% at 257.3 U/ml.
Statistical analysis
Preliminary analysis
Pre- treatment salivary cortisol and pre-treatment saliv-
ary alpha amylase were defined as the concentrations of
the hormones in the samples collected at 1200 h. Pre-
treatment SBP, DBP, MAP and HR were defined as the
value recorded at 1145 h. Peak height for cortisol was
defined as the highest value obtained for each individual
between 1230 h- 1400 h, inclusive. Since the SAM sys-
tem appears to have had a secondary activation at the
time of the break to use the bathroom, peak height for
salivary alpha amylase was defined as the highest value
obtained from 1230 h-1330 h. Peak height for all cardio-
vascular parameters was defined as the highest value ob-
tained between 1245 h-1330 h. Reactivity was calculated
by subtracting the pre-treatment value from the peak
height for all parameters. Area under the curve (AUC)
with respect to increase was calculated for cortisol using
values between 1200 h – 1400 h, for salivary alpha amyl-
ase using values between 1200 h – 1330 h and for SBP,
DBP, MAP and HR using values between 1145 h – 1330 h
after the subtraction of the pre-treatment value from each
data point. AUC for all parameters were calculated using
the trapezoid rule utilising Sigmaplot graphing software
(Systat Software Inc., California, USA).
Analysis
Data were analysed using the Statistical Package for the
Social Sciences software version 21.0 for windows (SPSS.
Inc, Chicago, USA). Kolmogorov-Smirnov and Shapiro –
Wilk tests were conducted to test for normality. Tests
for homogeneity of variance were conducted using
Levene’s test of equality of error variances. Descriptive
characteristics were compared between groups using
univariate analysis of variance. Salivary cortisol, salivary
alpha amylase, blood pressures and heart rate were com-
pared within and between subjects using repeated mea-
sures analysis of variance. The within subjects factor was
time and the between subjects factor was treatment.
When the time effect for salivary cortisol was considered
separately in each group, only data from 1200 h-1400 h
were included. Derived salivary cortisol, salivary alpha
amylase and cardiovascular parameters (pre- treatment,
peak height, reactivity and area under the curve) were
Table 2 Mean (±SEM) total energy and macronutrients
consumed by lean and overweight/obese men
Lean Overweight/Obese p value*
(n = 19) (n = 17)
Total energy (kJ) 2895 ± 245 3015 ± 235 0.728
Protein (g) 27.2 ± 2.1 29.9 ± 2.5 0.396
Carbohydrate (g) 65.2 ± 6.4 73.0 ± 5.4 0.362
Fat (g) 37.2 ± 4.3 35.7 ± 4.3 0.801
*Univariate analysis of variance.
0.8
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variance. P < 0.05 was considered statistically significant.
Results
Participants
Data were collected from 24 lean and 22 overweight/
obese men who were eligible for the study. Two lean and
5 overweight/obese were subsequently excluded from the
analyses due to insufficient saliva volume to undertake the
assays for cortisol and alpha amylase. It was ascertained
in initial analyses that the lean group was significantly
(p = 0.054) older (64.2 ± 1.1 years) than the overweight/
obese group (61.1 ± 1.1 years). To remove this effect
(to ensure that men were age matched by group), the
results of the three oldest lean men were excluded
from the final analyses. Consequently, 19 lean and 17
overweight/obese were included in the final study co-
hort. The men that were excluded did not differ sig-
nificantly from the final cohort in any of the baseline
characteristics.
Participant characteristics
Overweight/obese men had significantly higher body weight,
BMI, percentage body fat and significantly lower percentage
lean mass compared with lean men (p <0.001 for all)
(Table 1). Girth measurements were also higher in over-
weight/obese men with a 19% larger waist circumference (p
< 0.001), a 10% larger hip circumference (p < 0.001) and a
10% larger waist-to-hip ratio (p < 0.001) compared with lean
men.
Total energy and macronutrient intake
Lean and overweight/obese men consumed similar amounts
of total energy, protein, carbohydrate and fat (Table 2).
There were no significant differences between the groups in
these parameters. Overall (both groups combined), the mealTable 1 Mean (±SEM) baseline descriptive characteristics
in lean and overweight/obese men
Lean Overweight/Obese p value*
(n = 19) (n = 17)
Age (years) 63.3 ± 1.1 61.1 ± 1.1 0.166
Height (cm) 172.0 ± 1.4 174.8 ± 1.4 0.179
Weight (kg) 69.7 ± 1.6 93.8 ± 2.3 <0.001
BMI (kg/m2) 23.5 ± 0.3 30.6 ± 0.6 <0.001
% Fat 20.2 ± 1.1 28.1 ± 0.9 <0.001
% Lean 79.3 ± 1.1 72.0 ± 0.9 <0.001
Waist circumference (cm) 86.1 ± 1.5 106.9 ± 1.5 <0.001
Hip circumference (cm) 97.5 ± 1.2 109.2 ± 1.3 <0.001
WHR 0.88 ± 0.01 0.98 ± 0.01 <0.001
*Univariate analysis of variance.
BMI body mass index, % Fat percentage body fat, % Lean percentage lean
mass, WHR waist to hip ratio.consumed by the participants consisted of 22% protein, 53%
carbohydrates and 25% fat.
Salivary cortisol
Saliva concentrations of cortisol in lean and overweight/
obese men are shown in Figure 1 and Table 3. In re-
sponse to lunch, saliva concentrations of cortisol differed
significantly between lean and overweight/obese men
(time*treatment, p = 0.008; Figure 1). Further, separate
analysis of the groups revealed a significant effect of
time in overweight/obese men (p = 0.005) but not in lean
men (p = 0.384). The peak height of cortisol concentra-
tions in the overweight/obese group (0.654 ± 0.09 μg/dL)
was significantly higher than pre-treatment concentra-
tions (0.345 ± 0.03 μg/dL) (p = 0.003). This corresponded
to an 86% increase in cortisol concentrations from pre-
treatment concentrations to the peak height of the re-
sponse in overweight/obese men. There were no signifi-
cant differences between the groups in peak height for
the cortisol response (Table 3). Area under the curve for
cortisol was significantly higher in the overweight/obese
men compared with lean men (p = 0.039) and there was1200h 1300h 1400h
Sa
liv
a 
co
rti
so
l (u
g/d
L)
0.0
0.2
0.4
0.6
lean (n = 19) 
overweight/obese (n = 17)
lunch
Figure 1 Mean (±SEM) concentrations of salivary cortisol (μg/dL)
in lean and overweight/obese men from 1145 h to 1400 h (time
effect p < 0.001; time*treatment interaction p = 0.008; treatment
effect p = 0.643). The box labelled “lunch” represents the timing of
the lunch period and the hashed box represents the timing of the
break to use the bathroom.
Table 3 Mean (±SEM) pre-treatment salivary cortisol,
peak height of salivary cortisol, salivary cortisol reactivity
and area under the curve for lean and overweight/obese
men
Lean Overweight/Obese p value*
(n = 19) (n = 17)
Pre-treatment (μg/dL) 0.411 ± 0.04 0.345 ± 0.03 0.204
Peak height (μg/dL) 0.532 ± 0.06 0.654 ± 0.09 0.251
Reactivity (μg/dL) 0.121 ± 0.06 0.309 ± 0.08 0.083
AUC (μg*min/dL) −3.250 ± 19.49 10.182 ± 18.03 0.039
* Univariate analysis of variance.
AUC Area under the curve.
Table 4 Mean (±SEM) pre-treatment salivary alpha
amylase, peak height of salivary alpha amylase, salivary
alpha amylase reactivity and area under the curve for
lean and overweight/obese men
Lean Overweight/Obese p value*
(n = 19) (n = 17)
Pre-treatment (U/ml) 135 ± 19.6 126 ± 16.5 0.716
Peak height (U/ml) 228 ± 33.7 242 ± 37.1 0.771
Reactivity (U/ml) 93 ± 25.0 117 ± 26.4 0.510
AUC (U*min/ml) 2288 ± 1427 2863 ± 4254 0.751
*Univariate Analysis of Variance.
AUC Area under the curve.
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weight/obese men compared with lean men (p = 0.083;
Table 3). Repeated measures analysis of variance re-
vealed that there was a significant overall effect of time
(p < 0.001; Figure 1). There was no significant between
subjects effect indicating that there were no significant
overall differences between the groups (p = 0.643).Salivary alpha amylase
Saliva concentrations of alpha amylase in lean and over-
weight/obese men are shown in Figure 2 and Table 4.
Repeated measures analysis of variance revealed that
there was a significant effect of time (p < 0.001; Figure 2).
Overall (both groups combined), the peak height of sal-
ivary alpha amylase concentrations (235 ± 24.6 μg/dL)
was significantly higher than pre-treatment concentra-
tions (131 ± 12.8 μg/dL) (p < 0.001). Overall, there was
an 80% increase in salivary alpha amylase concentrations
from pre-treatment concentrations to the peak of the re-
sponse (both groups combined).1200h 1300h 1400h
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300 lean (n = 19) 
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Figure 2 Mean (±SEM) concentrations of salivary alpha amylase
(U/ml) in lean and overweight/obese men from 1145 h to
1400 h (time effect p< 0.001; time*treatment interaction p= 0.195;
treatment effect p = 0.898). The box labelled “lunch” represents the
timing of the lunch period and the hashed box represents the
timing of the break to use the bathroom.Saliva concentrations of alpha amylase in response
to the lunch did not differ significantly between lean
and overweight/obese men (time*treatment, p = 0.195;
Figure 2) and accordingly, there were no significant
differences between the groups in peak height, reactivity
or area under the curve for the salivary alpha amylase
response (Table 4). There was no significant between
subjects effect (p = 0.898) indicating that there were no
significant overall differences between the groups.
Cardiovascular parameters
Cardiovascular parameters in lean and overweight/obese
men are shown in Figure 3 and Table 5.
Systolic blood pressure
There was a significant effect of time for systolic blood
pressure (p = 0.001; Figure 3a). Overall (both groups com-
bined), the peak height of systolic blood pressure (129 ±
3 mmHg) was significantly higher than pre-treatment sys-
tolic blood pressure (124 ± 3 mmHg) (p = 0.03).
Systolic blood pressure in response to the lunch did
not differ significantly between lean and overweight/
obese men (time*treatment, p = 0.726; Figure 3a). Sys-
tolic blood pressure reactivity and area under the curve
did not differ between the two groups (Table 5). How-
ever, overweight/obese men had significantly higher pre-
treatment and peak height values for systolic blood pres-
sure compared with the lean men (p < 0.05 for both;
Table 5). There was also a trend towards systolic blood
pressure being significantly higher overall in the over-
weight/obese men compared with the lean men (be-
tween subjects effect, p = 0.058).
Diastolic blood pressure
Repeated measures analysis of variance revealed that there
was a significant effect of time for diastolic blood pressure
(p < 0.001; Figure 3b). Overall (both groups combined),
the peak height of diastolic blood pressure (74 ± 2 mmHg)
was significantly higher than pre-treatment diastolic blood
pressure (71 ± 2 mmHg) (p = 0.03).
Figure 3 Mean (±SEM) a) systolic blood pressure (mmHg), b)
diastolic blood pressure (mmHg), c) mean arterial pressure
(mmHg) and d) heart rate (bpm) in lean and overweight/obese
men from 1145 h to 1400 h (time effect p = 0.001, 0.000, 0.007,
0.087, respectively; time*treatment interaction p = 0.726, 0.898,
0.713, 0.620, respectively; treatment effect p = 0.058, 0.022,
0.026, 0.709, respectively). The boxes labelled “lunch” represent
the timing of the lunch period and the hashed boxes represent the
timing of the break to use the bathroom.
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not differ significantly between lean and overweight/
obese men (time*treatment, p = 0.898; Figure 3b). This
finding was consistent with a lack of significant differ-
ence in reactivity and area under the curve of diastolic
blood pressure between lean and overweight/obese men
(Table 5). Nevertheless, overweight/obese men had a sig-
nificantly higher pre-treatment diastolic blood pressure
and peak height compared with the lean men (Table 5).
There was a significant between subjects effect indicat-
ing that the overweight/obese men had higher diastolic
blood pressure overall than the lean men (p = 0.022).
Mean arterial pressure
There was a significant effect of time for mean arterial
pressure (p = 0.007; Figure 3c). Overall (both groupsTable 5 Mean (±SEM) pre-treatment, peak height, reactivity
and area under the curve for SBP, DBP, MAP and HR in lean
and overweight/obese men
Lean Overweight/
Obese
(n = 17)
p value*
(n = 19)
SBP Pre-treatment (mmHg) 119 ± 3 129 ± 3 0.030
Peak height (mmHg) 125 ± 3 134 ± 4 0.046
Reactivity (mmHg) 6 ± 2 5 ± 3 0.820
AUC (mmHg*min) −173 ± 143 −19 ± 178 0.489
DBP Pre-treatment (mmHg) 68 ± 2 75 ± 2 0.027
Peak height (mmHg) 71 ± 1 76 ± 3 0.017
Reactivity (mmHg) 3 ± 2 3 ± 2 0.956
AUC (mmHg*min) −15 ± 108 33 ± 131 0.780
MAP Pre-treatment (mmHg) 85 ± 2 93 ± 2 0.022
Peak height (mmHg) 89 ± 1 95 ± 2 0.026
Reactivity (mmHg) 3 ± 2 2 ± 2 0.588
AUC (mmHg*min) 55 ± 118 254 ± 142 0.289
HR Pre-treatment (bpm) 64 ± 3 64 ± 3 0.968
Peak height (bpm) 67 ± 2 69 ± 3 0.628
Reactivity (bpm) 3 ± 2 5 ± 1 0.483
AUC (bpm*min) 56 ± 134 −109 ± 99 0.337
*Univariate Analysis of Variance.
SBP Systolic blood pressure, DBP Diastolic blood pressure, MAP Mean arterial
pressure, HR Heart rate, AUC Area under the curve.
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mean arterial pressure (92 ± 2 mmHg) being significantly
higher than pre-treatment (89 ± 2 mmHg) (p = 0.06).
Mean arterial pressure in response to the lunch did
not differ significantly between lean and overweight/
obese men (time*treatment, p = 0.713; Figure 3c). Mean
arterial pressure reactivity and area under the curve
were similar in overweight/obese men compared with
lean men (Table 5). Overweight/obese men had a signifi-
cantly higher pre-treatment and peak height for mean
arterial pressure compared with lean men (Table 5).
There was also a significant between subjects effect indi-
cating that the overweight/obese men had higher mean ar-
terial pressure overall compared with lean men (p = 0.026).
Heart rate
There was no significant effect of time for heart rate
(p = 0.087; Figure 3d). Overall (both groups combined),
the peak height of heart rate (68 ± 3 bpm) was not sig-
nificantly different to pre-treatment heart rate (64 ±
3 bpm) (p = 0.16).
Heart rate following lunch did not differ significantly
between lean and overweight/obese men (time*treat-
ment, p = 0.620; Figure 3d) and accordingly, there were
no significant differences between the groups in peak
height, heart rate reactivity or area under the curve for
heart rate (Table 5). There were also no significant dif-
ferences between the groups in pre-treatment heart rate
(Table 5) and there was no significant overall between
subjects effect indicating that there were no significant
overall differences between the groups for heart rate
(p = 0.709).
Discussion
Our hypothesis that overweight/obese men will have
greater cortisol and alpha amylase responses to the chal-
lenge of food consumption compared with lean men was
partially supported. Overweight/obese men showed a
greater activation of the HPA axis to food intake com-
pared with lean men as indicated by the higher response
of salivary cortisol. Contrary to our hypothesis, both
groups showed a similar salivary alpha amylase response
to consumption of food. Systolic blood pressure, dia-
stolic blood pressure, mean arterial pressure and heart
rate responses were also similar between the groups in
response to lunch indicating that there is no difference
in SAM system activation in response to food intake be-
tween lean and overweight/obese men.
The finding that only overweight/obese men showed a
significant HPA axis response to food intake is of par-
ticular importance. This is in accord with the findings of
Vicennati and colleagues in women with abdominally
distributed body fat (waist to hip ratio > 0.85) in re-
sponse to the ingestion of a high carbohydrate meal [13].Nevertheless, it should be noted that the meal used by
Vicennati et al. contained 89% carbohydrates whereas
ours only contained 53% carbohydrates. This suggests
that even moderate levels of carbohydrates can elicit a
significant HPA axis response in overweight/obese men.
The notion that even moderate levels of carbohydrates
can elicit significant HPA axis activity is of particular
significance, especially in the context of the modern day
western diets including large quantities of refined carbo-
hydrates [25]. This could even be more relevant to indi-
viduals who are already overweight/obese and are on a
high carbohydrate diet because regular elevations of cor-
tisol may further complicate metabolic anomalies that
may already exist. Findings by Martens et al. further re-
iterate the importance of the carbohydrate content in
eliciting cortisol responses to food intake [14]. They re-
ported that protein or fat intake can decrease cortisol re-
sponses, whereas ingestion of carbohydrates increased
cortisol responses. Therefore, it appears that the carbo-
hydrate content of a meal can play a significant role in
activating the HPA axis.
Lean men did not show a significant elevation in corti-
sol after consumption of the standardised lunch in the
current experiment. This is contrary to the findings of
Gibson and colleagues in 1999 where they investigated
cortisol responses to a high protein (39%) lunch in
healthy men [12]. It should be noted that the contribu-
tion of protein towards the total energy in the current
experiment was only 22%. Therefore, it appears that a
protein content as low as 22% can elicit significant HPA
axis response in overweight/obese men. This also sug-
gests that a significant HPA axis response is dependent
on a higher protein content only in lean men. The en-
ergy intake in the current study is also similar to that of
the average Australian energy intake for men (22% pro-
tein, 45% carbohydrate and 32% fat) as reported in the
1995 National Nutrition Survey [26]. Therefore, it is
highly likely that overweight/obese men will consume a
diet that can elicit a significant cortisol response every
time they eat.
Abdominal obesity can be associated with disrupted
endocrine as well as neural feedback from the brain-gut
axis to the HPA axis [27]. Food can stimulate the secre-
tion of certain peptides/hormones such as insulin, leptin,
ghrelin, cholecystokinin, and pancreatic peptide Y which
can in turn have an impact on the HPA axis activity
[28,29]. It has been reported that these feedback path-
ways are malfunctioning in obese individuals [30]. Over-
weight/obese men in the current study had significantly
higher waist to hip ratios compared with the lean men
suggesting that they had a higher proportion of abdom-
inally distributed fat. Therefore, it is possible that ab-
dominally based body fat distribution in the overweight/
obese men may have contributed towards the higher
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anisms that may play a role in overweight/obese individ-
uals having a higher cortisol response to food intake. For
example, differences in stimulation of the HPA axis
compared with lean individuals, perhaps through in-
creased noradrenergic drive, decreased negative feedback
and/or increased corticotrophin releasing hormone and
arginine vasopressin synthesis and secretion are plaus-
ible mechanisms for the pattern of results observed [31].
Cortisol plays a major role in metabolism [32] and it is
well known that variations in cortisol can have a signifi-
cant impact on nutrient absorption [33,34]. Cortisol con-
tributes towards lipolysis and proteolysis thus it increases
the plasma free fatty acid availability. This could poten-
tially accentuate the deposition of abdominal fat or further
complicate existing manifestations of obesity. Further-
more, hyperactivity of the HPA axis has been shown to be
associated with cardiovascular disease [35], type 2 diabetes
[36] and anxiety and depression [37].
None of the previous studies in this area has investi-
gated the effects of food consumption on the activity of
the SAM system in lean and overweight/obese men. Our
results indicate that, with the exception of heart rate, all
of the SAM system parameters that were measured in
the current experiment (salivary alpha amylase, systolic
blood pressure, diastolic blood pressure and mean arter-
ial pressure) increased in response to lunch (time effect
for all parameters p <0.05). These findings partially con-
cur with the reports of Harthoorn et al. who found in-
creases in sympathetic nervous system activity after
ingestion of a standardised meal (15-20% protein, 35-40%
fat and 40-45% carbohydrate) in a group of healthy men
and women [38]. Increases in sympathetic nervous system
activity are to be expected as eating places a demand on
the cardiovascular system. It has been reported that the
postprandial increase in heart rate together with the sub-
sequent increase in cardiac output facilitates the rise in
demand for blood flow to the visceral areas [39]. However,
there was no such effect on heart rate in the current ex-
periment. The reduction in systolic blood pressure, dia-
stolic blood pressure and mean arterial pressure in the
postprandial period (i.e., 1245 h-1330 h in the current ex-
periment) may be a result of the reduction in resistance to
blood flow in the mesenteric vessels. Another plausible ex-
planation could be that the satiety hormones are having
an inhibitory effect on the sympathetic nervous system
during this period [40,41]. These findings suggest that
there is no differential SAM system response to food in-
take in men based on the level of adiposity.
It has previously been reported that sympathetic nervous
system response to food intake can be bi-phasic in nature
[38]. Harthoorn et al. reported a secondary increase in sym-
pathetic nervous system activity about 45–50 minutes post
ingestion of a meal. This could be attributed to thephysiological changes that happen due to the gastro-
intestinal mechanisms of digestion of food. While this
previously reported increase is somewhat similar to the
secondary rise in salivary alpha amylase and blood
pressure parameters in the current experiment, the in-
crease in the current experiment occurred with a greater
delay (75–90 minutes) after the ingestion of the meal. The
secondary increase in our experiment coincided with the
bathroom break that was offered to participants after the
1330 h sample collection. Consequently, it is not possible
to determine in the current experiment if this secondary
increase in SAM system activity is a result of gastrointes-
tinal mechanisms of food ingestion or merely an artefact
of the participants physically moving during the bathroom
break.
The current experiment is the first of its kind to investi-
gate both SAM system and HPA axis responses simultan-
eously in response to food intake. While the measurement
of saliva cortisol (which is in a high concentration per vol-
ume range; ug/dl range) has been shown to be unaffected
by blood contamination due to micro-injury of the oral
cavity [23], blood contamination has been shown to influ-
ence the measurement of steroid hormones present in the
very low concentration per volume range (pg/ml range)
including salivary testosterone [23], salivary oestradiol [42]
and salivary progesterone [42]. Therefore, to support the
outcomes of the current study, future research could con-
firm these findings in a similarly designed study that mea-
sures plasma cortisol instead of salivary cortisol. Future
experiments could also consider females and participants
of different age groups.
Conclusions
In conclusion, this experiment showed that increased
adiposity in men was associated with hyperactivity of the
HPA axis after the ingestion of a meal consisting of 22%
protein, 53% carbohydrates and 25% fat. This suggests
that ingesting a standardised meal can result in differen-
tial HPA axis but not SAM system activation in over-
weight/obese men of 50–70 years compared with age
matched lean men.
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